Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672526 | SCV000797638 | uncertain significance | Bardet-Biedl syndrome 10 | 2018-02-02 | criteria provided, single submitter | clinical testing | |
3billion | RCV000672526 | SCV002059078 | uncertain significance | Bardet-Biedl syndrome 10 | 2022-01-03 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported to be associated with BBS10 related disorder (PMID:19797195, PS1_P). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.688, PP3_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
Laboratory of Medical Genetics |
RCV000735925 | SCV000839561 | pathogenic | Bardet-Biedl syndrome | 2018-09-15 | no assertion criteria provided | provider interpretation |